CME Group Inc (CME) Given Consensus Recommendation of “Buy” by Analysts
CME Group Inc (NASDAQ:CME) has been assigned an average recommendation of “Buy” from the fifteen research firms that are currently covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $181.67.
Several equities research analysts have recently weighed in on CME shares. Jefferies Financial Group reissued a “buy” rating and set a $190.00 price objective on shares of CME Group in a research note on Wednesday, September 5th. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research note on Monday, July 16th. Deutsche Bank reissued a “buy” rating and set a $192.00 price objective (up from $185.00) on shares of CME Group in a research note on Thursday, October 11th. Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a research report on Wednesday, October 3rd. Finally, Berenberg Bank set a $184.00 target price on CME Group and gave the stock a “hold” rating in a research report on Thursday, September 20th.
In other news, President Bryan T. Durkin sold 11,509 shares of the firm’s stock in a transaction on Monday, August 6th. The stock was sold at an average price of $162.01, for a total value of $1,864,573.09. Following the completion of the sale, the president now owns 64,862 shares of the company’s stock, valued at $10,508,292.62. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Ronald A. Pankau sold 260 shares of the stock in a transaction on Thursday, August 9th. The stock was sold at an average price of $163.17, for a total value of $42,424.20. Following the sale, the director now owns 3,900 shares of the company’s stock, valued at $636,363. The disclosure for this sale can be found here. In the last ninety days, insiders sold 29,188 shares of company stock valued at $4,973,607. 0.43% of the stock is currently owned by insiders.
Shares of CME traded up $1.17 during trading hours on Tuesday, hitting $178.64. 2,027,027 shares of the company were exchanged, compared to its average volume of 1,777,486. The firm has a market cap of $60.65 billion, a PE ratio of 28.95, a P/E/G ratio of 3.39 and a beta of 0.64. The company has a quick ratio of 1.08, a current ratio of 1.09 and a debt-to-equity ratio of 0.15. CME Group has a one year low of $134.09 and a one year high of $183.79.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, October 25th. The financial services provider reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.03. The business had revenue of $904.20 million during the quarter, compared to analyst estimates of $910.50 million. CME Group had a return on equity of 9.18% and a net margin of 113.67%. On average, equities research analysts anticipate that CME Group will post 6.63 EPS for the current fiscal year.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Further Reading: Insider Trading – What You Need to Know
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.